Volume 17, Number 8—August 2011
Research
Cost-effectiveness of Sick Leave Policies for Health Care Workers with Influenza-like Illness, Brazil, 2009
Table 5
Cost category |
2-d + reassessment, n = 415 HCWs |
7-d, n = 169 HCWs |
|||||
---|---|---|---|---|---|---|---|
Unit cost, R$ |
No. units |
Cost, R$ |
Unit cost, R$ |
No. units |
Cost, R$ |
||
Direct costs | |||||||
Diagnosis | |||||||
Medical consultation | 7.90 | 1,037.50 | 8,196.25 | 7.90 | 185.90 | 1,468.61 | |
Real-time PCR | 100.00 | 184.00 | 18,400.00 | 100.00 | 60.00 | 6,000.00 | |
Respiratory swab | 0.46 | 184.00 | 84.64 | 0.46 | 60.00 | 27.60 | |
Outpatient care | |||||||
Oseltamivir | 112.40 | 415 | 46,646.00 | 112.40 | 169 | 18,995.60 | |
Antimicrobial drugs | 2.40 | 83 | 199.20 | 2.40 | 34 | 81.60 | |
Medication for symptoms | 2.95 | 291 | 858.45 | 2.95 | 118 | 348.10 | |
Hospitalization, d | 1,196.39 | 30.00 | 35,891.70 | 1,871.06 | 4.00 | 7,484.24 | |
Staff replacement, d | |||||||
Physician | 858.51 | 50.50 | 43,354.76 | 858.51 | 17.50 | 15,023.93 | |
Nurse | 257.07 | 131.60 | 33,830.41 | 257.07 | 166.60 | 42,827.86 | |
Nurse assistant | 167.09 | 421.40 | 70,411.73 | 167.09 | 419.30 | 70,060.84 | |
Nonmedical |
10.00 |
1.50 |
6,225.00 |
10.00 |
0.10 |
169.00 |
|
Indirect costs | |||||||
Productivity losses, d | |||||||
Physician | 381.23 | 101.00 | 38,504.23 | 381.23 | 35.00 | 13,343.05 | |
Nurse | 307.15 | 188.00 | 57,744.20 | 307.15 | 238.00 | 73,101.70 | |
Nurse assistant |
157.18 |
602.00 |
94,622.36 |
157.18 |
599.00 |
94,150.82 |
|
Total | 454,968.92 | 343,082.94 | |||||
*HCW, health care worker; 2-d + reassessment, 2-day sick leave plus reassessment every 2 days until asymptomatic policy; 7-d, 7-day sick leave policy; R$, Brazilian reals (R$1.80 = US $1.00).
†Round-trip bus fare for reassessment.
Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.